Amneal Pharmaceuticals (AMRX) Restructuring Costs (2017 - 2026)
Amneal Pharmaceuticals (AMRX) recorded Restructuring Costs of $7.6 million in Q2 2026, up 642.2% from $1.02 million a year earlier and up 47.5% from the prior quarter.
Amneal Pharmaceuticals (AMRX) Restructuring Costs (2017 - 2026) Analysis & Trends
On a TTM basis, Amneal Pharmaceuticals' Restructuring Costs came in at $15.37 million as of Jun 30, 2026, up 579.9% year-over-year; for FY2025, it came in at $4.21 million, up 78.7% from FY2024.
- Annual Restructuring Costs has increased for three straight years, though with a five-year compound annual growth rate of -14.1% (FY2020 to FY2025).
- Across earlier years, Restructuring Costs came in at $2.36 million in FY2024 (+34.6%), $1.75 million in FY2023 (+23.1%), $1.42 million in FY2022 (-82.5%) and $8.1 million in FY2021 (-10.0%).
- The Q2 2026 figure is the highest quarterly Restructuring Costs since Q3 2019.
- On a year-over-year basis, Restructuring Costs has increased for three consecutive quarters, with growth averaging 297.8% over the last eight quarters.
- Peak year-over-year performance for Restructuring Costs in the last five years was growth of 802.5% in Q1 2026, against a decline of 98.5% in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $5.15 million (Q1 2026), $2.47 million (Q4 2025) and $143,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Amneal Pharmaceuticals | 6.55 Bn | 5.82 Bn | 334.51 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.60 Mn |
| Mar 31, 2026 | 5.15 Mn |
| Dec 31, 2025 | 2.47 Mn |
| Sep 30, 2025 | 143,000.00 |
| Jun 30, 2025 | 1.02 Mn |
| Mar 31, 2025 | 571,000.00 |
| Dec 31, 2024 | 493,000.00 |
| Sep 30, 2024 | 172,000.00 |
| Jun 30, 2024 | 220,000.00 |
| Mar 31, 2024 | 1.47 Mn |
| Dec 31, 2023 | 114,000.00 |
| Sep 30, 2023 | 1.04 Mn |
| Jun 30, 2023 | 82,000.00 |
| Mar 31, 2023 | 510,000.00 |
| Dec 31, 2022 | 109,000.00 |
| Sep 30, 2022 | 581,000.00 |
| Mar 31, 2022 | 731,000.00 |
| Dec 31, 2021 | 7.31 Mn |
| Sep 30, 2021 | 425,000.00 |
| Mar 31, 2021 | 363,000.00 |
Amneal Pharmaceuticals Restructuring Costs API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=restructuring-costs&ticker=AMRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "restructuring-costs", "ticker": "AMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=restructuring-costs&ticker=AMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();